Introduction: P2 receptors

Current Topics in Medicinal Chemistry

Volumn 4, Issue 8, 2004, Pages 793-803

  Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTITHROMBOCYTIC AGENT; ATROPINE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; CLOPIDOGREL; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; ION CHANNEL; LIGAND; NEUROLEPTIC AGENT; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE RECEPTOR; RECEPTOR SUBTYPE; SURAMIN; THEOPHYLLINE; TICLOPIDINE; UNINDEXED DRUG;

CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CHANNEL GATING; CLINICAL TRIAL; DIABETES MELLITUS; DRUG MECHANISM; DRUG TARGETING; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATION; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY TRACT DISEASE; REVIEW; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; UROGENITAL TRACT DISEASE;

ANIMALS; HUMANS; ION CHANNEL GATING; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 3042806532     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043451014     Document Type: Review

References (156)

1. Drury, A.N.; Szent-Görgyi, A. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol. (Lond) 1929, 68, 213-237.
2. Burnstock, G. Purinergic nerves. Pharmacol. Rev. 1972, 24, 509-581.
3. Burnstock, G. Do some nerve cells release more than one transmitter? Neuroscience 1976, 1, 239-248.
4. Burnstock, G, A basis for distinguishing two types of purinergic receptor. In Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Straub, R.W. & Bolis, L., eds), Raven Press, New York 1978, pp. 107-118.
5. Van Calker, D.; Müller, M.; Hamprecht, B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 1979, 33, 999-1005.
6. Londos, C.; Cooper, D.M.; Wolff, J. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA 1980, 77, 2551-2554.
7. 2-purinoceptor? Gen. Pharmacol. 1985, 16, 433-440.
8. Gordon, J.L. Extracellular ATP: effects, sources and fate. Biochem. J. 1986, 233, 309-319.
9. O'Connor, S.E.; Dainty, I.A.; Leff, P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci. 1991, 12, 137-141.
10. 2Y purinoceptors? Pharmacol. Ther. 1994, 64, 445-475.
11. 2-purinergic receptors for extracellular ATP. Am. J. Respir. Cell Mol. Biol. 1991, 4, 295-300.
12. Lustig, K.D.; Shiau, A.K.; Brake, A.J.; Julius, D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA 1993, 90, 5113-5117.
13. Webb, T.E.; Simon, J.; Krishek, B.J.; Bateson, A.N.; Smart, T.G.; King, B.F.; Burnstock, G.; Barnard, E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 1993, 324, 219-225.
14. Brake, A.J.; Wagenbach, M.J.; Julius, D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 1994, 371, 519-523.
15. 2X receptor for extra-cellular ATP. Nature 1994, 371, 516-519.
16. Ralevic, V.; Burnstock, G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50, 413-492.
17. Khakh, B.S.; Burnstock, G.; Kennedy, C.; King, B.F.; North, R.A.; Séguéla, P.; Voigt, M.; Humphrey, P.P.A. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 2001, 53, 107-118.
18. Burnstock, G. Introduction: ATP and its metabolites as potent extracellular agonists. In: Current Topics in Membranes, Purinergic Receptors and Signalling Ed E. M. Schwiebert. Academic Press, San Diego. 2003, Vol 54, pp 1-27.
19. Burnstock, G. Purinoceptors: Ontogeny and Phylogeny. Drug Dev. Res. 1996, 39, 204-242.
20. Abbracchio, M.P.; Burnstock, G. Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 1998, 78, 113-145.
21. Olsson, R.A.; Pearson, J.D. Cardiovascular purinoceptors. Physiol. Rev. 1990, 70, 761-845.
22. Dubyak, G.R.; El Moatassim, C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 1993, 265, C577-C606.
23. Burnstock, G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 1997, 36, 1127-1139.
24. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 1995, 377, 432-435.
25. 3 receptors. J. Neurosci. 1997, 17, 6529-6533.
26. 6 channel subunits coassemble into a novel heteromeric ATP receptor. J. Neurosci. 1998, 18, 7152-7159.
27. 5 receptor subunits reveals a novel ATP-gated ion channel. Mol. Pharmacol, 1998, 54, 989-993.
28. 5 isoforms. Mol. Pharmacol. 1999, 56, 720-727.
29. 6 subunits in Xenopus oocytes. J. Neurosci. 2000, 20, 4871-4877.
30. Torres, G.E.; Egan, T.M.; Voigt, M.M. Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem. 1999, 274, 6653-6659.
31. North, R.A.; Surprenant, A. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 563-580.
32. 4a receptors. Brain Res. Mol. Brain Res. 1999, 64, 246-254.
33. Zimmermann, H. Extracellular purine metabolism. Drug Dev. Res. 1996, 39, 337-352.
34. 1 receptor: similarities to the platelet ADP receptor. Mol. Pharmacol. 1998, 53, 727-733.
35. 6-methyl 2′-deoxyadenosine 3′, 5′-bisphosphate. Br. J. Pharmacol. 1998, 124, 1-3.
36. Brown, S.G.; King, B.F.; Kim, Y.-C.; Jang, S.Y.; Burnstock, G.; Jacobson, K.A. Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev. Res. 2000, 49, 253-259.
37. 4 nucleotide receptor. Special Report. Br. J. Pharmacol. 1998, 124, 428-430.
38. King, B.F.; Townsend-Nicholson, A.; Burnstock, G. Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol. Sci. 1998, 19, 506-514.
39. Bogdanov, Y.D.; Dale, L.; King, B.F.; Whittock, N.; Burnstock, G. Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J. Biol. Chem. 1997, 272, 12583-12590.
40. Adrian, K.; Bernhard, M.K.; Breitinger, H.-G.; Ogilvie, A. Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells. Biochim. Biophys. Acta 2000, 1492, 127-138.
41. Hollopeter, G.; Jantzen, H.-M.; Vincent, D.; Li, G.; England, L.; Ramakrishnan, V.; Yang, R.-B.; Nurden, P.; Nurden, A.; Julius, D.; Conley, P.B. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409, 202-207.
42. Communi, D.; Gonzalez, N.S.; Detheux, M.; Brezillon, S.; Lannoy, V.; Parmentier, M.; Boeynaems, J.M. Identification of a novel human ADP receptor coupled to G(i). J. Biol. Chem. 2001, 276, 41479-41485.
43. Chambers, J.K.; Macdonald, L.E.; Sarau, H.M.; Ames, R.S.; Freeman, K.; Foley, J.J.; Zhu, Y.; McLaughlin, M.M.; Murdock, P.; McMillan, L.; Trill, J.; Swift, A.; Aiyar, N.; Taylor, P.; Vawter, L.; Naheed, S.; Szekeres, P.; Hervieu, G.; Scott, C.; Watson, J.M.; Murphy, A.J.; Duzic, E.; Klein, C.; Bergsma, D.J.; Wilson, S.; Livi, G.P. A G protein-coupled receptor for UDP-glucose. J. Biol. Chem. 2000, 275, 10767-10771.
44. Freeman, K.; Tsui, P.; Moore, D.; Emson, P.C.; Vawter, L.; Naheed, S.; Lane, P.; Bawagan, H.; Herrity, N.; Murphy, K.; Sarau, H.M.; Ames, R.S.; Wilson, S.; Livi, G.P.; Chambers, J.K. Cloning, Pharmacology, and Tissue Distribution of G-Protein-Coupled Receptor GPR105 (KIAA0001) Rodent Orthologs. Genomics 2001, 78, 124-128.
45. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 1996, 16, 2495-2507.
46. Vulchanova, L.; Arvidsson, U.; Riedl, M.; Wang, J.; Buell, G.; Surprenant, A.; North, R.A.; Elde, R. Differential distribution of two ATP-gated channels (P2X receptors) determined by imunocytochemistry. Proc. Natl. Acad. Sci. USA 1996, 93, 8063-8067.
47. 3 purinoceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol. Cell. Neurosci. 1998, 12, 256-268.
48. 1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am. J. Physiol. 1998, 274, F799-F804.
49. Xiang, Z.; Bo, X.; Burnstock, G. Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia. Neurosci. Lett. 1998, 256, 105-108.
50. 2 receptor immunoreactivity in the rat hypothalamus. Brain Res. 1998, 813, 390-397.
51. 7. Drug Dev. Res. 1999, 47, 189-195.
52. 3 receptor immunoreactive nerves in rat taste buds. Neuroreport 1999, 10, 1107-1111.
53. 7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res. 1999, 296, 599-605.
54. Gröschel-Stewart, U.; Bardini, M.; Robson, T.; Burnstock, G. P2X receptors in the rat duodenal villus. Cell Tissue Res. 1999, 297, 111-117.
55. Bardini, M.; Lee, H.Y.; Burnstock, G. Distribution of P2X receptor subtypes in the rat female reproductive tract at late pro-oestrus/early oestrus. Cell Tissue Res. 2000, 299, 105-113.
56. 3 receptors. Am. J. Respir. Cell Mol. Biol. 2000, 23, 52-61.
57. Lee, H.-Y.; Bardini, M.; Burnstock, G. Distribution of P2X receptors in the urinary bladder and ureter of the rat. J. Urol. 2000, 163, 2002-2007.
58. Lee, H.Y.; Bardini, M.; Burnstock, G. P2X receptor immunoreactivity in the male genital organs of the rat. Cell Tissue Res. 2000, 300, 321-330.
59. 3 receptors in rat sensory neurons. Neuroreport 1998, 9, 2245-2250.
60. 1 receptors in the rat cerebellum. Cell Tissue Res. 1998, 294, 253-260.
61. 2 receptor immunoreactivity in vascular endothelial cells in rat brain. Endothelium 2000, 7, 93-98.
62. 6 receptors in the rat hypothalamo-neurohypophysial system: an ultrastructural study with ExtrAvidin and colloidal gold-silver immunolabelling. Neuroscience 2001, 106, 621-631.
63. 2 receptor immunoreactivity in the rat hypothalamoneurohypophysial system. J. Neurocytol. 1999, 28, 495-504.
64. 4 receptors in rat vascular smooth muscle: an in situ hybridization and RT-PCR study. J. Vasc. Res. 1998, 35, 179-185.
65. 2X (purinergic) receptor distributions in rat blood vessels. J. Auton. Nerv. Syst. 1999, 75, 147-155.
66. Lewis, C.J.; Evans, R.J. Comparison of P2X receptors in rat mesenteric, basilar and septal (coronary) arteries. J. Auton. Nerv. Syst. 2000, 81, 69-74.
67. Lewis, C.J.; Surprenant, A.; Evans, R.J. 2′, 3′-O-(2, 4, 6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP)-a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. Br. J. Pharmacol. 1998, 124, 1463-1466.
68. 1 receptors. Br. J. Pharmacol. 1999, 128, 981-988.
69. Braun, K.; Rettinger, J.; Ganso, M.; Kassack, M.; Hildebrandt, C.; Ullmann, H.; Nickel, P.; Schmalzing, G.; Lambrecht, G. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364, 285-290.
70. 3 receptors. Drug Dev. Res. 2001, 53, 281-291.
71. 2 purinoceptor to ATP revealed by changing extracellular pH. Br. J. Pharmacol. 1996, 117, 1371-1373.
72. 4 receptors by extracellular pH and zinc. Br. J. Pharmacol. 1999, 126, 762-768.
73. Burnstock, G. P2X receptors in sensory neurones. Br. J. Anaesth. 2000, 84, 476-488.
74. Rong, W.; Burnstock, G.; Spyer, K.M. P2X purinoceptor-mediated excitation of trigeminal lingual nerve terminals in an in vitro intra-arterially perfused rat tongue preparation. J. Physiol. 2000, 524, 891-902.
75. Alavi, A.M.; Dubyak, G.R.; Burnstock, G. Immunohistochemical evidence for ATP receptors in human dental pulp. J. Dental Res. 2001, 80, 476-483.
76. 3 knockout mice reveal a major sensory role for urothelially released ATP. J. Neurosci. 2001, 21, 5670-5677.
77. Glass, R.; Townsend-Nicholson, A.; Burnstock, G. P2 receptors in the thymus: expression of P2X and P2Y receptors in adult rats, an immunohistochemical and in situ hybridisation study. Cell Tissue Res. 2000, 300, 295-306.
78. Glass, R.; Burnstock, G. Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid. J. Anat. 2001, 198, 569-579.
79. Burnstock, G. Expanding field of purinergic signaling. Drug Dev. Res. 2001, 52, 1-10.
80. 6, in developing chick skeletal muscle. Dev. Dyn. 1999, 216, 442-449.
81. Ryten, M.; Hoebertz, A.; Burnstock, G. Sequential expression of three receptor subtypes for extracellular ATP in developing rat skeletal muscle. Dev. Dyn. 2001, 221, 331-341.
82. 7). Science 1996, 272, 735-738.
83. 1 receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. Neuropharmacology, 2000, 39, 2054-2066.
84. Burnstock, G. Purinergic cotransmission. Brain Res. Bull. 1999, 50, 355-357.
85. Burnstock, G. & Ralevic, V. Cotransmission. In The Pharmacology of Vascular Smooth Muscle Oxford University Press, Oxford. (Garland, C.J. & Angus, J.A., eds), 1996, pp. 210-232.
86. Burnstock, G. Purinergic signalling in lower urinary tract. In Handbook of Experimental Pharmacology, Volume 151/I. Purinergic and Pyrimidinergic Signalling I - Molecular, Nervous and Urinogenitary System Function (Abbracchio, M.P. & Williams, M., eds), Springer-Verlag, Berlin. pp. 2001, 423-515.
87. Burnstock, G. Purinergic signalling in gut. In Handbook of Experimental Pharmacology, Volume 151/II. Purinergic and Pyrimidinergic Signalling II - Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function (Abbracchio, M.P. & Williams, M., eds), Springer-Verlag, Berlin. 2001, pp. 141-238.
88. Evans, R.J.; Derkach, V.; Surprenant, A. ATP mediates fast synaptic transmission in mammalian neurons. Nature 1992, 357, 503-505.
89. Silinsky, E.M.; Gerzanich, V.; Vanner, S.M. ATP mediates excitatory synaptic transmission in mammalian neurones. Br. J. Pharmacol. 1992, 106, 762-763.
90. Edwards, F.A.; Gibb, A.J.; Colquhoun, D. ATP receptor-mediated synaptic currents in the central nervous system. Nature 1992, 359, 144-147.
91. Nieber, K.; Poelchen, W.; Illes, P. Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br. J. Pharmacol. 1997, 122, 423-430.
92. Pankratov, Y.; Lalo, U.; Castro, E.; Miras-Portugal, M.T.; Krishtal, O. ATP receptor-mediated component of the excitatory synaptic transmission in the hippocampus. Prog. Brain Res. 1999, 120, 237-249.
93. Nörenberg, W.; Illes, P. Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 362, 324-339.
94. Masino, S.A. & Dunwiddie, T.V. Role of purines and pyrimidines in the central nervous system. In Handbook of Experimental Pharmacology. Purinergic and Pyrimidinergic Signalling I - Molecular, Nervous and Urinogenitary System Function (Abbracchio, M.P. & Williams, M., eds), Springer-Verlag, Berlin. 2001, pp. 251-288.
95. Dunn, P.M.; Zhong, Y.; Burnstock, G. P2X receptors in peripheral neurones. Prog. Neurobiol. 2001, 65, 107-134.
96. Abbracchio, M.P., Ceruti, S., Bolego, C., Puglisi, L., Burnstock, G., & Cattabeni, F. Trophic roles of P2-purinoceptors in central nervous system astroglial cells. In P2 Purinoceptors: Localization, Function and Transduction Mechanisms. Ciba Foundation Symposium John Wiley and Sons, Chichester. 1996, 198 pp. 142-148.
97. Neary, J.T.; Rathbone, M.P.; Cattabeni, F.; Abbracchio, M.P.; Burnstock, G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 1996, 19, 13-18.
98. Loubatières-Mariani, M.M.; Chapal, J. Purinergic receptors involved in the stimulation of insulin and glucagon secretion. Diabete Metab. 1988, 14, 119-126.
99. Schöfl, C.; Ponczek, M.; Mader, T.; Waring, M.; Benecke, H.; von zur Mühlen A.; Mix, H.; Cornberg, M.; Böpker, K.H.W.; Manns, M.P.; Wagner, S. Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am. J. Physiol. 1999, 276, G164-G172.
100. Kunapuli, S.P.; Daniel, J.L. P2 receptor subtypes in the cardiovascular system. Biochem. J. 1998, 336, 513-523.
101. Mayer, C.; Quasthoff, S.; Grafe, P. Differences in the sensitivity to purinergic stimulation of myelinating and non-myelinating Schwann cells in peripheral human and rat nerve. Glia 1998, 23, 374-382.
102. Chen, Z.-P.; Kratzmeier, M.; Levy, A.; McArdle, C.A.; Poch, A.; Day, A.; Mukhopadhyay, A.K.; Lightman, S.L. Evidence for a role of pituitary ATP receptors in the regulation of pituitary function. Proc. Natl. Acad. Sci. USA 1995, 92, 5219-5223.
103. Lee, P.S.; Squires, P.E.; Buchan, A.M.; Yuen, B.H.; Leung, P.C. P2-purinoreceptor evoked changes in intracellular calcium oscillations in single isolated human granulosa-lutein cells. Endocrinology, 1996, 137, 3756-3761.
104. Tomic, M.; Jobin, R.M.; Vergara, L.A.; Stojilkovic, S.S. Expression of purinergic receptor channels and their role in calcium signaling and hormone release in pituitary gonadotrophs. Integration of P2 channels in plasma membrane- and endoplasmic reticulum-derived calcium oscillations. J. Biol. Chem. 1996, 271, 21200-21208.
105. Sperlágh, B.; Mergl, Z.; Jurányi, Z.; Vizi, E.S.; Makara, G.B. Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis. J. Endocrinol. 1999, 160, 343-350.
106. 2+ response in rat thyroid FRTL-5 cells. Eur. J. Pharmacol. 2000, 390, 43-50.
107. Eltze, M.; Ullrich, B. Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney. Eur. J. Pharmacol. 1996, 306, 139-152.
108. Huber-Lang, M.; Fischer, K.G.; Gloy, J.; Schollmeyer, P.; Kramer-Guth, A.; Greger, R.; Pavenstadt, H. UTP and ATP induce different membrane voltage responses in rat mesangial cells. Am. J. Physiol 1997, 272, F704-F711.
109. Cha, S.H.; Sekine, T.; Endou, H. P2 purinoceptor localization along rat nephron and evidence suggesting existence of subtypes P2Y1 and P2Y2. Am. J. Physiol 1998, 274, F1006-F1014.
110. van der, Weiden, L.; Adams, D.J.; Morris, B.J. Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways. Hypertension 2000, 36, 1093-1098.
111. Bailey, M.A.; Imbert-Teboul, M.; Turner, C.; Marsy, S.; Srai, K.; Burnstock, G.; Unwin, R.J. Axial distribution and characterization of basolateral P2Y receptors along the rat renal tubule. Kidney Int. 2000, 58, 1893-1901.
112. + absorption in M-1 mouse cortical collecting duct cells. J. Physiol 2000, 524 Pt 1, 77-90.
113. Dockrell, M.E.; Noor, M.I.; James, A.F.; Hendry, B.M. Heterogeneous calcium responses to extracellular ATP in cultured rat renal tubule cells. Clin. Chim. Acta 2001, 303, 133-138.
114. Webb, T.E.; Barnard, E.A. Molecular biology of P2Y receptors expressed in the nervous system. Prog. Brain Res. 1999, 120, 23-31.
115. Neary, J.T.; Kang, Y.; Bu, Y.; Yu, E.; Akong, K.; Peters, C.M. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidy linositol-specific phospholipase C/calcium pathway. J. Neurosci. 1999, 19, 4211-4220.
116. 35S]ATPαS binding proteins associated with G- proteins. Neurochem. Int. 1999, 34, 303-317.
117. 1 purinergic receptor in the human brain: striking neuronal localisation. J. Comp. Neurol. 2000, 421, 374-384.
118. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain Res. Mol. Brain Res. 2000, 78, 50-58.
119. Zundorf, G.; Schafer, R.; Vohringer, C.; Halbfinger, E.; Fischer, B.; Reiser, G. Novel modified adenosine 5′-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation. Biochem. Pharmacol. 2001, 61, 1259-1269.
120. 1 suggests a role for nucleotide signalling in development of the chick embryo. Dev. Dyn. 1999, 214, 152-158.
121. Müller, C.E.; Stein, B. Adenosine receptor antagonists: structures and potential therapeutic applications. Curr. Pharm. Des. 1996, 2, 501-530.
122. Broadley, K.J. Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases. Exp. Opin. Ther. Patents 2000, 10, 1169-1692.
123. Impagnatiello, F.; Bastia, E.; Ongini, E.; Monopoli, A. Adenosine receptors in neurological disorders. Emerging Therapeutic Targets 2001, 4, 635-664.
124. Kaiser, S.M.; Quinn, R.J. Adenosine receptors as potential therapeutic targets. Drug Discov. Today 1999, 4, 542-551.
125. Agteresch, H.J.; Dagnelie, P.C.; van den Berg, J.W.O.; Wilson, J.H. Adenosine triphosphate: established and potential clinical applications. Drugs 1999, 58, 211-232.
126. Williams, M. Clinical opprortunities in purinergic neuromodulation. In Handbook of Experimental Pharmacology: Purinergic and Pyrimidinergic Signalling II (Abbracchio, M.P. & Williams, M., eds), Springer, Berlin. 2001, pp. 407-434.
127. Burnstock, G.; Williams, M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J. Pharmacol. Exp. Ther. 2000, 295, 862-869.
128. Fischer, B. Therapeutic applications of ATP-(P2)-receptors agonists and antagonists. Exp. Opin. Ther. Patents 1999, 9, 385-399.
129. Burnstock, G.; Ralevic, V. New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br. J. Plast. Surg. 1994, 47, 527-543.
130. Erlinge, D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen. Pharmacol. 1998, 31, 1-8.
131. Brass, S. Cardiovascular biology. Small cells, big issues. Nature 2001, 409, 145, 147.
132. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 2001, 348, 1329-1339.
133. Yusuf, S.; Zhao, F.; Mehta, S.R.; Chrolavicius, S.; Tognoni, G.; Fox, K.; The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 2001, 345, 494-502.
134. Vidal, M.; Hicks, P.E.; Langer, S.Z. Differential effects of α, β-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch. Pharmacol. 1986, 332, 384-390.
135. 2-receptor mRNA levels in congestive heart failure. Life Sci. 1999, 65, 1195-1206.
136. Knutsen, L.J.S. & Murray, T.F. Adenosine and ATP in epilepsy. In Purinergic Approaches in Experimental Therapeutics (Jacobson, K.A. & Jarvis, M.F., eds), Wiley-Liss, New York. 1997, pp. 423-447.
137. Burnstock, G. A unifying purinergic hypothesis for the initiation of pain. Lancet 1996, 347, 1604-1605.
138. 3-deficient mice. Nature 2000, 407, 1011-1015.
139. Biaggioni, I.; Feoktistov, I.; Sheller, J.R.; Grant, M.; Belardinelli, L.; Wells, J.N. Development of new selective A2B antagonists with greater potency than enprofylline. Drug Dev. Res. 2000, 50, 104.
140. Schulman, E.S.; Glaum, M.C.; Post, T.; Wang, Y.; Raible, D.G.; Mohanty, J.; Butterfield, J.H.; Pelleg, A. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am. J. Respir. Cell Mol. Biol. 1999, 20, 530-537.
141. Yerxa, B.R. Therapeutic use of nucleotides in respiratory and ophthalmic diseases. Drug Dev. Res. 2000, 52, 196-201.
142. Stutts, M.J. & Boucher, R.C. Cystic fibrosis gene and functions of CFTR implications of dysfunctional ion transport for pulmonary pathogenesis. In Cystic Fibrosis in Adults (Yankaskas, J.R. & Knowles, M.R., eds), Lippincott-Raven, Philadelphia. 1999, pp. 3-25.
143. 2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994, 90, 1287-1293.
144. Burnstock, G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol. Sci. 2001, 22, 182-188.
145. Gür, S.; Öztürk, B. Altered relaxant responses to adenosine and adenosine 5′-triphosphate in the corpus cavernosum from men and rats with diabetes. Pharmacology 2000, 60, 105-112.
146. Knight, G.E., Bodin, P., de Groat, W.C., & Burnstock, G. Ureter epithelium on distension. Am. J. Physiol. 2002, 282, F281-F288.
147. Jackson, E.K. P1 and P2 receptors in the renal system. In Purinergic and Pyrimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function (Abbracchio, M.P. & Williams, M., eds),. Springer, Berlin. 2001, pp. 33-71
148. 3 is increased in human inflammatory bowel disease. Neurogastroenterol. Motil. 2001, 13, 365-369.
149. 1 receptor on bone cells. FASEB J. 2001, 15, 1139-1148.
150. Dixon, S.J.; Sims, S.M. P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Dev. Res. 2000, 49, 187-200.
151. 7 receptor: a pivotal role in inflammation and immunomodulation. Drug Dev. Res. 1998, 45, 207-213.
152. Burnstock, G. Overview of P2 receptors: possible functions in immune cells. Drug Dev. Res. 2001, 53, 53-59.
153. Calvert, R.C., Moules, E.W., Thompson, C.S., Mikhailidis, D.P., Morgan, R.J., & Burnstock, G. ATP inhibits proliferation of human prostate cancer cell line (PC-3) via P2-purinergic receptors. Prostate Cancer and Prostatic Diseases 4, 17. 2001.
154. 2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int. J. Colorectal Dis. 2001, 16, 154-166.
155. Loubatières-Mariani, M.M., Hillaire-Buys, D., Chapal, J., Bertrand, G., & Petit, P. P2 purinoceptor agonists: new insulin secretogogues potentially useful in the treatment of non-insulin-dependent diabetes mellitus. In Purinergic Approaches in Experimental Therapeutics (Jacobson, K.A. & Jarvis, M.F., eds), Wiley-Liss, New York. 1997, pp. 253-260.
156. Housley, G.D. Physiological effects of extracellular nucleotides in the inner ear. Clin. Exp. Pharmacol. Physiol. 2000, 27, 575-580.